Skip to content

An overview of white blood cells' functioning in patients with periodontitis

Characterization of functional oral polymorphonuclear neutrophils in periodontitis patients: an observational case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN15252886
Enrollment
15
Registered
2017-08-11
Start date
2014-10-20
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis Oral Health Periodontal disease, unspecified

Interventions

Venous blood and oral rinse samples were obtained from 19 patients with untreated periodontitis and 16 control subjects without periodontitis for PMN isolation. Cell numbers were counted and apoptosis

Sponsors

University of Amsterdam
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with untreated periodontitis 2. The presence of bone loss on = 1/3 of the root length on minimum 2 non-adjacent teeth on vertical bite-wing radiographs not older than 12 months 3. Aged 18 and over

Exclusion criteria

Exclusion criteria: 1. A history of pathologic conditions that are known to systemically affect PMN functionality (such as hematological disorders, diabetes mellitus, antibiotics use within the last 6 months, recent history of illness or fever, allergies, alcoholism and pregnancy) 2. Less than 20 teeth 3. Removable partial dentures 4. Night guards 5. Orthodontic banding 6. (Peri) oral piercings 7. Apparent oral lesions

Design outcomes

Primary

MeasureTime frame
The presence of PMNs in the oral cavity of periodontitis patients, measured using flow cytometry directly after sampling. All samples were analyzed using flow cytometry on the same day.

Secondary

MeasureTime frame
1. Cell counts, measured using a Muse cell counting device 2. Cell membrane integrity, measured with flow cytometric analysis using propidium iodide staining 3. PMN expression markers of cell activation: CD11b, CD63, CD66b and corrected for non-specific binding of isotype control antibodies 4. Presence of constitutive oxygen radicals (ROS), detected using dihydrorhodamine 123 5. Presence of ROS in response to stimulation, determined in samples incubated with phorbol myristate acetate (PMA) or Fusobacterium nucleatum All outcomes measured at a single timepoint

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026